Page last updated: 2024-12-05

lethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID8196
CHEMBL ID1867205
SCHEMBL ID434543
MeSH IDM0187492

Synonyms (66)

Synonym
butyl carbitol rhodanate
thiocyanic acid, 2-(2-butoxyethoxy)ethyl ester
butoxyrhodanodiethyl ether
1-butoxy-2-(2-thiocyanoethoxy)ethane
ethane, 1-butoxy-2-(2-thiocyanatoethoxy)-
nsc3534
.beta.-butoxy-.beta.'-thiocyanodiethyl ether
2-(2-butoxyethoxy)ethyl thiocyanate
wln: ncs2o2o4
lethane
2-[2-(butoxy)ethoxy]ethyl thiocyanic acid ester
lethane 384 special (use 2 code nos. 010002 and 010101)
ethanol, thiocyanate
nsc-3534
2-butoxy-2'-thiocyanodiethyl ether
lethane 384
112-56-1
ent 6
butyl carbitol thiocyanate
NCGC00091820-01
ccris 5986
2-(2-butoxyethoxy)ethylthiokyanat [czech]
1-butoxy-alpha-(2-thiocyanoethoxy)ethane
2-(2-butoxyethoxy)ethylthiocyanate
2-(2-(butoxy)ethoxy)ethyl thiocyanic acid ester
ai3-00006
ethanol, 2-(2-butoxyethoxy)-, thiocyanate
caswell no. 084
beta-butoxy-beta'-thiocyano diethyl ether
beta-butoxy-beta'-thiocyanodiethyl ether
2-(2-(butoxy)ethoxy) ester of thiocyanic acid
lethane 384 regular
nsc 3534
brn 1812307
2-(2-butoxyethoxy)ethyl ester of thiocyanic acid
hsdb 1517
einecs 203-985-7
beta-butoxy beta'-thiocyano diethyl ether
epa pesticide chemical code 010002
NCGC00091820-02
2-(2-butoxyethoxy)ethylthiokyanat
unii-z8anl9b54i
z8anl9b54i ,
dtxsid6024674 ,
tox21_303547
dtxcid304674
NCGC00257458-01
cas-112-56-1
NCGC00258869-01
tox21_201317
AKOS024332353
thiocyanic acid,2-(2-butoxyethoxy)ethyl ester
SCHEMBL434543
diethylene glycol monobutyl ether thiocyanate
lethane 384 [mi]
ent-6
lethane 384 [hsdb]
1-butoxy-.alpha.-(2-thiocyanoethoxy)ethane
JVGPVVUTUMQJKL-UHFFFAOYSA-N
CHEMBL1867205
2-[2-butoxyethoxy]ethyl thiocyanate
1-(2-(2-thiocyanatoethoxy)ethoxy)butane
FT-0711425
2-[2-butoxyethoxy]ethylthiocyanate
Q27295138
1-butoxy-2-[2-(cyanosulfanyl)ethoxy]ethane
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
interleukin 8Homo sapiens (human)Potency47.30790.047349.480674.9780AID651758
GLI family zinc finger 3Homo sapiens (human)Potency0.84820.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency27.40750.000221.22318,912.5098AID743063
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.56230.000214.376460.0339AID588532
retinoid X nuclear receptor alphaHomo sapiens (human)Potency29.03140.000817.505159.3239AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency51.18650.001530.607315,848.9004AID1224841
pregnane X nuclear receptorHomo sapiens (human)Potency29.55980.005428.02631,258.9301AID1346982
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency23.08650.001019.414170.9645AID588537; AID743191
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency2.56540.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.39 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]